Asia-pacific Clinical Trials Support Services Market Forecast 2022-2030
KEY FINDINGS
The Asia-Pacific clinical trials support services market is estimated to surge with an 8.21% CAGR over the assessment period, 2022 and 2030. The availability of high-quality data at a low price and the presence of a huge population drive market growth.
MARKET INSIGHTS
The Asia-Pacific clinical trials support services market growth evaluation entails the analysis of Japan, China, Singapore, South Korea, Taiwan, India, Australia & New Zealand, Thailand, and Rest of Asia-Pacific. In India, clinical trials are surging. Therefore, clinical trial support services are expected to propel in the next few years. Further, in 2020, there were various top therapy areas for industry-sponsored clinical trials in India, which helped to support the demand for clinical trials during the forecast period.
South Korea has emerged as an attractive country to conduct clinical trials because it offers clinical experts who conduct the clinical trials, infrastructure, dense population, supportive government regulations, etc. Sponsors prefer conducting clinical trials in South Korea due to its speed and quality. With the high density of the population, patients are easily available for participation and the advanced hospitals available in the country. South Korea has an added advantage with access to a larger population.
On the other hand, in Taiwan, the development of the international biotechnology industry is increasing rapidly. Different types of research and development have been advanced to the clinical trial stage. Also, the competition is rising between Japan and South Korea, and as a result, the Taiwan government set up a one-stop shop to provide domestic and international partners with key information on Taiwan’s clinical trial environment.
COMPETITIVE INSIGHTS
Some key market players include EPS Corporation, CMIC Group, WuXi AppTec, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Rising Prevalence Of Chronic Disease & Virus Outbreaks
- 3.1.2. Benefits Of Clinical Trial Support Services
- 3.2. Key Restraints
- 3.2.1. Availability Of Open-source/Freeware Software
- 3.2.2. Stringent Regulations
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Clinical Trials Support Services Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Opportunity Matrix
- 4.5. Vendor Landscape
- 4.6. Value Chain Analysis
- 4.7. Key Buying Criteria
- 4.7.1. Performance
- 4.7.2. Ease Of Use
- 4.7.3. Security
- 4.7.4. Cost-effectiveness
- 4.8. Regulatory Framework
- 5. Market By Phase
- 5.1. Phase I
- 5.2. Phase Ii
- 5.3. Phase Iii
- 5.4. Phase Iv
- 6. Market By Sponsor
- 6.1. Pharmaceutical & Biopharmaceutical Companies
- 6.2. Medical Device Companies
- 6.3. Other Sponsors
- 7. Market By Service
- 7.1. Clinical Trial Site Management
- 7.2. Administrative Staff
- 7.3. Patient Recruitment Management
- 7.3.1. Patient Recruitment & Registry Services
- 7.3.2. Patient Retention
- 7.3.3. Other Patient Recruitment Management
- 7.4. Irb
- 7.5. Data Management
- 7.6. Other Services
- 8. Geographical Analysis
- 8.1. Asia-pacific
- 8.1.1. Market Size & Estimates
- 8.1.2. Key Growth Enablers
- 8.1.3. Key Challenges
- 8.1.4. Key Players
- 8.1.5. Country Analysis
- 8.1.5.1. China
- 8.1.5.2. Japan
- 8.1.5.3. India
- 8.1.5.4. South Korea
- 8.1.5.5. Taiwan
- 8.1.5.6. Singapore
- 8.1.5.7. Thailand
- 8.1.5.8. Australia & New Zealand
- 8.1.5.9. Rest Of Asia-pacific
- 9. Competitive Landscape
- 9.1. Key Strategic Developments
- 9.1.1. Mergers & Acquisitions
- 9.1.2. Product Launches & Developments
- 9.1.3. Partnerships & Agreements
- 9.1.4. Business Expansions & Divestitures
- 9.2. Company Profiles
- 9.2.1. Advanced Clinical
- 9.2.2. Alcura
- 9.2.3. Charles River Laboratories Inc
- 9.2.4. Clinipace
- 9.2.5. Cti Clinical Trial And Consulting Services Inc
- 9.2.6. Icon Plc
- 9.2.7. Iqvia
- 9.2.8. Kcr
- 9.2.9. Labcorp Drug Development
- 9.2.10. Medpace
- 9.2.11. Parexel
- 9.2.12. Psi Cro
- 9.2.13. Syneos Health
- 9.2.14. Worldwide Clinical Trials
- 9.2.15. Wuxi Apptec
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook